Nifedipine Tablet, Film Coated, Extended Release
Product Images NDC 55154-4157

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 55154-4157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (C98ecf77 Ae9a 438b 9bad Ffbed25d95bc 00)

Bag Label (C98ecf77 Ae9a 438b 9bad Ffbed25d95bc 00)
Nifedipine extended-release tablets, USP 60 mg, film-coated and oral dosage form. The label shows a package of 10 tablets distributed by Cardinal Health 107, LLC. It includes storage instructions, a warning about child resistance, and distributor information for Ingenus Pharmaceuticals and Major Pharmaceuticals. The product NDC is 55154-4157.*
FDA Label Image

01 (Image 01)

01 (Image 01)
Chemical structure diagram of nifedipine, showing its molecular framework including nitro group, ester groups, and aromatic rings as the active ingredient.*
FDA Label Image

02 (Image 02)

02 (Image 02)
A data table comparing the percentage of patients experiencing adverse effects on Nifedipine extended-release tablets versus placebo. Adverse effects listed include headache, fatigue, dizziness, constipation, and nausea, with corresponding percentages for 707 and 266 subjects respectively in each group.*
FDA Label Image

03 (Image 03)

03 (Image 03)
A data table comparing the percentage incidence of various adverse effects in subjects taking Nifedipine extended-release capsules versus placebo. Adverse effects listed include dizziness, flushing, headache, weakness, nausea, muscle cramps, peripheral edema, nervousness, palpitations, dyspnea, and nasal congestion, with corresponding percentages for each group.*
FDA Label Image

04 (Image 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.